A PHASE 1/2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA (NDGBM OR RGBM) Conference

Wen, Patrick, Odia, Yazmin, Mehta, Minesh et al. (2020). A PHASE 1/2 STUDY OF SELINEXOR IN COMBINATION WITH STANDARD OF CARE THERAPY FOR NEWLY DIAGNOSED OR RECURRENT GLIOBLASTOMA (NDGBM OR RGBM) . NEURO-ONCOLOGY, 22 195-195.

cited authors

  • Wen, Patrick; Odia, Yazmin; Mehta, Minesh; Goldlust, Samuel; Tamir, Sharon; Shacham, Sharon; Wang, Hongwei; Sheehan, Heidi; Li, Kai

authors

date/time interval

  • November 19, 2020 -

publication date

  • November 1, 2020

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • ELECTR NETWORK

Conference

  • 25th Virtual Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology (SNO)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 195

end page

  • 195

volume

  • 22